Literature DB >> 8844623

Improved detection of replication-competent retrovirus.

S P Forestell1, J S Dando, E Böhnlein, R J Rigg.   

Abstract

Recombinant retroviral vectors are the predominant delivery system in human gene therapy protocols. Since contaminating replication-competent retrovirus (RCR) can arise during the production of retroviral vector supernatants, sensitive assays for the screening of supernatants are necessary. In this study, we present a marker rescue assay based upon a Mus dunni cell line stably transduced with a lacZ gene. We show that detection of RCR in vector supernatants by the M. dunni lacZ marker rescue assay or PG-4 S+ L- focus-forming assay is equally sensitive. By inoculating test supernatants under centrifugation (which we term spinoculation), we increased the sensitivity of detection of RCR 10 to 100-fold with the PG-4 S+ L- and lacZ marker rescue assays. While the spinoculation protocol had no adverse effects on cells, spinoculation of high titer vector supernatants onto PG-4 cells resulted in some cytotoxicity, making identification of RCR positive cultures difficult. However, spinoculation of vector supernatants onto M. dunni lacZ cells resulted in no cytotoxicity, and also partially overcame inhibition of detection of low levels of RCR due to the presence of high titer replication-incompetent vector.

Entities:  

Mesh:

Year:  1996        PMID: 8844623     DOI: 10.1016/0166-0934(96)02052-6

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  14 in total

1.  Soluble receptor-induced retroviral infection of receptor-deficient cells.

Authors:  R Damico; P Bates
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.

Authors:  J Charles Whitbeck; Yi Zuo; Richard S B Milne; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Receptor-independent infection of murine coronavirus: analysis by spinoculation.

Authors:  Rie Watanabe; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells.

Authors:  Jia Guo; Weifeng Wang; Dongyang Yu; Yuntao Wu
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

5.  Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.

Authors:  Lina Rustanti; Hongping Jin; Dongsheng Li; Mary Lor; Haran Sivakumaran; David Harrich
Journal:  Virol Sin       Date:  2018-03-14       Impact factor: 4.327

6.  CD44 microbeads accelerate HIV-1 infection in T cells.

Authors:  Valeri H Terry; Ian C D Johnston; Celsa A Spina
Journal:  Virology       Date:  2009-04-23       Impact factor: 3.616

7.  Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.

Authors:  Daniel C Farley; Richard Bannister; Marie A Leroux-Carlucci; Nerys E Evans; James E Miskin; Kyriacos A Mitrophanous
Journal:  Hum Gene Ther Methods       Date:  2012-11-02       Impact factor: 2.396

8.  Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.

Authors:  Ramil Sapinoro; Ketna Volcy; W W Shanaka I Rodrigo; Jacob J Schlesinger; Stephen Dewhurst
Journal:  Virology       Date:  2008-01-14       Impact factor: 3.616

9.  Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.

Authors:  Chloe K Slichter; David P Friedrich; Rebecca J Smith; Paula N Walsh; Greg Mize; Julie L Czartoski; M Juliana McElrath; Nicole Frahm
Journal:  J Immunol Methods       Date:  2013-12-25       Impact factor: 2.303

10.  Replication-competent hybrids between murine leukemia virus and foamy virus.

Authors:  Evelina Shikova-Lekova; Dirk Lindemann; Thomas Pietschmann; Thomas Juretzek; Wolfram Rudolph; Ottmar Herchenröder; Hans R Gelderblom; Axel Rethwilm
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.